Jacobi, J;
Bircher, N;
Krinsley, J;
Agus, M;
Braithwaite, S. S;
Deutschman, C;
Freire, A. X;
Geehan, D;
Kohl, B;
Nasraway, S. A;
Rigby, M;
Sands, K;
Schallom, L;
Taylor, B;
Umpierrez, G;
Mazuski, J;
Schunemann, H.
Objective: To evaluate the literature and identify important aspects of insulin therapy that facilitate safe and effective infusion therapy for a defined glycemic end point. Methods: Where available, the literature was evaluated using Grades of Recommendation, Assessment, Development, and Evaluation (GRA...
Su objetivo principal es ayudar a optimizar el proceso diagnostico, identificando a los pacientes con bajo riesgo de tener una patología orgánica grave (fundamentalmente tumoral), los cuales podrían ser manejados de forma segura sin necesidad de realizar pruebas diagnosticas invasivas y/o derivaciones...
Dyspepsie/classification,
Dyspepsie/traitement médicamenteux,
Dyspepsie/diagnostic,
Programme clinique/organisation et administration,
Facteurs de risque,
Ulcère peptique/prévention et contrôle,
Qualité de vie,
Antiémétiques/usage thérapeutique,
Espagne,
Helicobacter pylori/pathogénicité,
Helicobacter pylori/effets des médicaments et des substances chimiques,
Pénicillines/usage thérapeutique
El objetivo de esta GPC es mejorar la atención preventiva, terapéutica y rehabilitadora a las personas con trastorno límite de la personalidad (TLP) en los dispositivos asistenciales del Sistema Nacional de Salud (SNS), en particular en los servicios especializados de salud mental. También se pretend...
Trouble de la personnalité limite/psychologie,
Trouble de la personnalité limite/thérapie,
Trouble de la personnalité limite/traitement médicamenteux,
Facteurs de risque,
Programme clinique/organisation et administration,
Neuroleptiques/usage thérapeutique,
Anticonvulsivants/usage thérapeutique,
Antidépresseurs/usage thérapeutique,
Anxiolytiques/usage thérapeutique,
Acides gras/usage thérapeutique,
Naloxone/usage thérapeutique,
Groupes d'entraide
This guideline covers assessing and managing people aged 14 years and over with coexisting severe mental illness (psychosis) and substance misuse. It aims to help healthcare professionals guide people with psychosis with coexisting substance misuse to stabilise, reduce or stop their substance misuse, to ...
This guideline covers the care and treatment of people aged 18 and over with generalised anxiety
disorder (chronic anxiety) or panic disorder (with or without agoraphobia or panic attacks). It aims
to help people achieve complete relief of symptoms (remission), which is associated with better
functioning...
Orientar a los profesionales sanitarios del ámbito de Atencion Primaria (AP) en el reconocimiento de los problemas y trastornos del sueño en la infancia y adolescencia, y sobre todo, en la selección de recomendaciones basadas en la evidencia científica disponible, de las intervenciones terapéuticas ...
El objetivo de esta guía de práctica clínica (GPC) es servir de instrumento para mejorar el manejo clínico de los niños y niñas con infección del tracto urinario (ITU). Estos pacientes son atendidos en diversos servicios de atención primaria, urgencias de centros hospitalarios y atención especia...
Since the beginning of the epidemic in the early 1980s, men who have sex with men (MSM) and transgender people have been disproportionately affected by the human immunodeficiency virus (HIV). The risk for infection remains high among them; and there has been a resurgence of HIV infection among MSM, parti...
This guideline covers the care and treatment of people aged 18 and over with generalised anxiety disorder (chronic anxiety) or panic disorder (with or without agoraphobia or panic attacks). It aims to help people achieve complete relief of symptoms (remission), which is associated with better functioning...
Increasing access to antiretroviral therapy (ART) has transformed the prognosis of HIVinfected patients in resource-limited settings (RLS). However, treatment coverage remains relatively low, and HIV diagnosis occurs at a late stage. As a result, many patients continue to die of HIV-related opportunistic...
Cryptococcose/diagnostic,
Flucytosine/administration et posologie,
Antifongiques/administration et posologie,
Infections opportunistes liées au SIDA/microbiologie,
Fluconazole/administration et posologie,
Amphotéricine B/administration et posologie,
Cryptococcose,
Cryptococcose/traitement médicamenteux,
Cryptococcose/prévention et contrôle,
Méningite cryptococcique/traitement médicamenteux,
Association de médicaments
